Breast Cancer: Targets and Therapy (Jun 2015)

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

  • Larsen S,
  • Butthongkomvong K,
  • Manikhas A,
  • Trishkina E,
  • Poddubuskaya E,
  • Matrosova M,
  • Srimuninnimit V,
  • Lindkær-Jensen S

Journal volume & issue
Vol. 2015, no. default
pp. 163 – 164

Abstract

Read online

Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group. Read the original article